The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $644,942 in first-year total cost, median $208,800.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BST-F (55)]3
Most frequent institutions
- CASE WESTERN RESERVE UNIVERSITY1
- UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN1
- VANDERBILT UNIVERSITY MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | High throughput screen for GPT2 inhibitors to target PIK3CA-mutant cancers1UH2CA223670-01 | WANG, ZHENGHE | CASE WESTERN RESERVE UNIVERSITY, OH | $208,800 | ZRG1 |
| 2017 | Identifying Small Molecules that Regulate Uterine Contractions1R21HD088830-01A1 | HERINGTON, JENNIFER L. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $276,500 | ZRG1 |
| 2017 | Identification of inhibitors of poly (ADP-ribose) glycohydrolase (PARG)1R21CA212732-01A1 | HERGENROTHER, PAUL | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $159,642 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.